TY - JOUR
T1 - Evaluation of Staging Systems for Cancer of the Nasal Vestibule
AU - Scheurleer, Willem Frederik Julius
AU - Tagliaferri, Luca
AU - Rijken, Johannes A
AU - Crescio, Claudia
AU - Rizzo, Davide
AU - Mattiucci, Gian Carlo
AU - Pameijer, Frank A
AU - de Bree, Remco
AU - Fionda, Bruno
AU - de Ridder, Mischa
AU - Bussu, Francesco
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/6/1
Y1 - 2023/6/1
N2 - Squamous cell carcinoma of the nasal vestibule is reported to account for less than one percent of all head and neck malignancies. It lacks a designated WHO ICD-O topography code, and multiple systems are available for the staging of this disease, which results in unwanted variability and the subsequent poor reliability of data. The aim of this study was to evaluate the currently available staging systems for cancer of the nasal vestibule, including the recently introduced classification by Bussu et al., which built on Wang's original concept but with clearer anatomical cutoffs. Different staging systems for cancer of the nasal vestibule (UICC nasal cavity, UICC skin cancer of the head and neck, Wang and Bussu et al.) were evaluated via a retrospective analysis of 148 patients. The staging system, per Bussu et al., had the most balanced allocation of patients among the stages. When using the Wang classification as a reference, stage migration occurred less frequently with the Bussu classification. The widespread adoption of a single staging system, as well as the introduction of a designated topography code for cancer of the nasal vestibule, could lead to more uniformity in data reporting and improve an understanding of the incidence and disease outcome. The newly proposed carcinoma of the nasal vestibule classification by Bussu et al. has the potential to improve the staging and allocation among stages. Further analysis of survival data is needed to assess which classification system is best suited for nasal vestibule carcinoma.
AB - Squamous cell carcinoma of the nasal vestibule is reported to account for less than one percent of all head and neck malignancies. It lacks a designated WHO ICD-O topography code, and multiple systems are available for the staging of this disease, which results in unwanted variability and the subsequent poor reliability of data. The aim of this study was to evaluate the currently available staging systems for cancer of the nasal vestibule, including the recently introduced classification by Bussu et al., which built on Wang's original concept but with clearer anatomical cutoffs. Different staging systems for cancer of the nasal vestibule (UICC nasal cavity, UICC skin cancer of the head and neck, Wang and Bussu et al.) were evaluated via a retrospective analysis of 148 patients. The staging system, per Bussu et al., had the most balanced allocation of patients among the stages. When using the Wang classification as a reference, stage migration occurred less frequently with the Bussu classification. The widespread adoption of a single staging system, as well as the introduction of a designated topography code for cancer of the nasal vestibule, could lead to more uniformity in data reporting and improve an understanding of the incidence and disease outcome. The newly proposed carcinoma of the nasal vestibule classification by Bussu et al. has the potential to improve the staging and allocation among stages. Further analysis of survival data is needed to assess which classification system is best suited for nasal vestibule carcinoma.
KW - nasal vestibule
KW - sinonasal cancer
KW - squamous cell carcinoma
KW - staging
UR - http://www.scopus.com/inward/record.url?scp=85161833856&partnerID=8YFLogxK
U2 - 10.3390/cancers15113028
DO - 10.3390/cancers15113028
M3 - Article
C2 - 37296990
SN - 2072-6694
VL - 15
SP - 1
EP - 10
JO - Cancers
JF - Cancers
IS - 11
M1 - 3028
ER -